PTSD and other mental health treatment with opioid antagonist... - Galyn Forster, MS, LPC (2021 Conference) (LDN, low dose naltrexone)

Lyme Disease - Darin Ingels, ND (2021 Conference) (LDN, low dose naltrexone)

Henoch-Schonlein Purpura - Sally Daughtrey, ND (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Daughtry explains Henoch-Schonlein (HSP), its triggers and complications (such as serious hidden infections often missed initially), and the use of Low Dose Naltrexone in treating HSP. Dr. Daughtry gives an in-depth look into one pediatric case she treated successfully with LDN.

Eosinophilic Esophagitis Is More Treatable Than You Think - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

Endogenous opioids modulate inflammation in the animal model of Multiple Sclerosis - Chirag Patel, MD (2021 Conference) (LDN, low dose naltrexone)

Crohn’s - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Dr. Pamela Smith discusses Crohn’s, an autoimmune disease, from both a conventional and personalized medicine approach. Siting research and her own clinical experience, Dr. Smith discusses traditional and complementary treatment, dietary and nutritional therapies, as well as the use of Low Dose Naltrexone in treating Crohn’s Disease.

Cooling the fire of lichen planopilaris - Apple Bodemer, MD (2021 Conference) (LDN, low dose naltrexone)

Autoimmunity in Families - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)